Welcome to our dedicated page for UBS ETRACS Alerian MLP Index ETN Series B SEC filings (Ticker: AMUB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The ETRACS Alerian MLP Index ETN Series B due July 18, 2042 (AMUB) is issued by UBS AG, a foreign private issuer that reports to the US Securities and Exchange Commission. UBS AG indicates that it files a registration statement on Form F-3, including a prospectus and supplements, for offerings of securities related to ETRACS ETNs such as AMUB. These documents set out the terms of the ETN and include a "Risk Factors" section that UBS urges investors to review before investing.
UBS AG also submits annual reports on Form 20-F and periodic reports on Form 6-K. In its Form 6-K filings, UBS provides information on capitalization, total debt issued, equity and other capital and liquidity metrics, as well as updates on regulatory developments and other corporate matters. UBS AG notes that its consolidated financial statements are prepared in accordance with IFRS Accounting Standards, and that certain 6-K reports are incorporated by reference into its Form F-3 registration statement.
For AMUB, the relevant SEC filings include the base prospectus, prospectus supplements and any pricing supplements that describe the specific terms of the ETRACS Alerian MLP Index ETN Series B. UBS’s public materials state that these offering documents are available through the SEC’s EDGAR system. They also clarify that the securities related to the offerings are not deposit liabilities and are not insured or guaranteed by the Federal Deposit Insurance Corporation or any other governmental agency of the United States, Switzerland or any other jurisdiction.
On this page, users can access AMUB-related SEC filings and associated issuer reports. The platform provides real-time updates from EDGAR and AI-powered summaries that explain the key points of lengthy documents, such as registration statements, prospectus supplements and UBS AG’s periodic reports. This allows investors to quickly identify disclosures that affect AMUB, including risk factor updates, capital and funding information, and other details relevant to UBS AG’s role as issuer of this senior unsecured ETN.
UBS AG is offering $810,000 in Trigger Autocallable Contingent Yield Notes linked to the common stock of GE Vernova Inc. The Notes pay periodic contingent coupons only if the underlying stock closes at or above a coupon barrier on observation dates; otherwise no coupon is paid. The Notes may be automatically called quarterly (beginning ~6 months after trade) if the underlying closes at or above the initial level, in which case holders receive principal plus any contingent coupon due on the call settlement date.
If not called, repayment of principal at maturity on April 13, 2029 is contingent: full principal is paid only if the final level is at or above the downside threshold (stated as $50.00, or 50.00% of the initial level); if below, holders suffer a loss equal to the underlying return and could lose their entire investment. The Notes carry issuer credit risk of UBS and an estimated initial value of $9.77 per $10 Note.
UBS AG is offering Trigger Autocallable Contingent Yield Notes linked to Rivian Automotive, Inc. stock due April 13, 2027. The Notes pay a periodic contingent coupon only if the underlying closing level on each observation date meets or exceeds a coupon barrier and will be automatically called early if the underlying closes at or above the initial level on any observation date. If not called, principal is repaid at maturity only if the final level is at or above the downside threshold; otherwise repayment at maturity is reduced pro rata to the underlying return and you may lose a substantial portion or all of your investment. Payments (coupons or principal) are subject to UBS credit risk. The estimated initial value on the trade date is $9.83 per Note and minimum investment is 100 Notes at $10 per Note.
UBS AG is offering Trigger Autocallable Contingent Yield Notes linked to the common stock of Boston Scientific Corporation due April 13, 2029. The Notes pay a contingent coupon only when the underlying closing level on an observation date is at or above the coupon barrier and may be automatically called early if the underlying closes at or above the initial level on any prior observation date. If not called and the final level is below the downside threshold, principal repayment at maturity is reduced pro rata to the underlying return, potentially resulting in a substantial or total loss of your investment. The Notes have a minimum purchase of 100 Notes ($1,000), an estimated initial value of $9.76 per $10 Note, and are unsecured obligations of UBS subject to UBS credit risk.
UBS AG offers $3,094,000 Trigger Autocallable Contingent Yield Notes linked to the common stock of Eli Lilly and Company, due April 13, 2029. The Notes pay a periodic contingent coupon only if the closing level of the underlying on each observation date meets or exceeds the coupon barrier; otherwise no coupon is paid. The Notes are automatically called early if the underlying’s closing level on any quarterly observation date (beginning after 6 months) is equal to or greater than the initial level, in which case holders receive principal plus any contingent coupon on the related coupon payment date. If not called, repayment at maturity depends on the final level: full principal is paid if the final level is at or above the downside threshold, but principal is reduced proportionally to the underlying return if the final level is below that threshold; investors could lose a significant portion or all of their investment. Key dates: trade date April 9, 2026, expected settlement April 13, 2026, final valuation date April 11, 2029, maturity April 13, 2029. The estimated initial value per Note was $9.75, and any payment is subject to UBS credit risk and to product terms subject to postponement in the event of a market disruption event.
UBS AG offers Trigger Autocallable Contingent Yield Notes linked to Micron Technology, Inc. stock due on or about April 13, 2028. The notes pay contingent coupons only if the underlying closes at or above specified coupon barriers on observation dates and can be automatically called early if the underlying closes at or above the initial level on an observation date. If not called, repayment at maturity is contingent: full principal is returned only if the final level is at or above the downside threshold; if the final level is below that threshold, principal is reduced proportionally to the underlying return, which could result in a total loss. Trade date is April 9, 2026 with settlement expected April 13, 2026. Minimum investment is 100 Notes at $10 per Note ($1,000). Estimated initial value range on the trade date is between $9.42 and $9.67. All payments are subject to UBS credit risk.
UBS AG is offering Trigger Autocallable Contingent Yield Notes linked to the common stock of GE Vernova Inc. The Notes have a trade date of April 9, 2026, expected settlement on April 13, 2026 and a final valuation and maturity in April 2029.
The Notes pay a contingent coupon only if the closing level of the underlying meets or exceeds a coupon barrier on specified quarterly observation dates; they are automatically called if the underlying equals or exceeds the initial level on any observation date. If not called, repayment at maturity depends on whether the final level is at or above a disclosed downside threshold; below that threshold investors suffer losses tied to the underlying return, potentially losing their entire principal. Example illustrative terms show a hypothetical contingent coupon rate of 13.17% per annum, an illustrative contingent coupon of $0.3293 per $10 Note, an illustrative downside threshold of $50.00 (50% of initial level), and an estimated initial value range of $9.39 to $9.64 per $10 Note. All payments, including contingent coupons and any principal repayment, are subject to UBS credit risk. This is a preliminary pricing supplement; final terms will be set on the trade date.
UBS AG priced a preliminary offering of Trigger Autocallable Contingent Yield Notes linked to the common stock of Rivian Automotive, Inc. The Notes pay periodic contingent coupons only if the underlying stock meets a coupon barrier on observation dates and may be automatically called early if the stock equals or exceeds the initial level on any observation date. At maturity, if not called, principal repayment is contingent on the final level relative to a downside threshold; if the final level is below that threshold, investors suffer a loss equal to the underlying return and could lose their entire investment. Trade date is April 9, 2026 with settlement on April 13, 2026 and maturity on April 13, 2027. Minimum investment is 100 Notes at $10 per Note. The document is a preliminary pricing supplement and final terms will be set on the trade date.
UBS AG offers a preliminary pricing supplement for $• Trigger Autocallable Contingent Yield Notes linked to the common stock of Boston Scientific Corporation, with a trade date of April 9, 2026 and expected settlement on April 13, 2026. The Notes mature on April 13, 2029 and feature periodic contingent coupons payable only if the underlying stock closes at or above a coupon barrier on each observation date. The Notes are subject to an automatic call if the underlying equals or exceeds the initial level on any prior observation date. If not called, principal repayment at maturity is contingent: full principal is paid if the final level is at or above a stated downside threshold; otherwise repayment is reduced pro rata to the underlying return, with potential for total loss. The document gives an estimated initial value range of $9.39 to $9.64 per $10 Note and includes illustrative terms (example contingent coupon rate 9.39% per annum). All payments are subject to the creditworthiness of UBS and final terms will be set on the trade date.
UBS AG is offering Trigger Autocallable Contingent Yield Notes linked to the common stock of Eli Lilly and Company due on or about April 13, 2029. The notes pay periodic contingent coupons only when the underlying meets a coupon barrier on observation dates and can be automatically called quarterly after six months if the underlying equals or exceeds the initial level. If not called, principal is repaid at maturity only if the final level is at or above a downside threshold; otherwise repayment falls with the underlying return and investors can lose a significant portion or all principal. Trade date is April 9, 2026 and settlement is expected on April 13, 2026. The estimated initial value range is $9.36 to $9.61 per $10 Note. Terms are subject to the accompanying product supplement and prospectus.
UBS AG offers $4,040,300 in Trigger Autocallable Contingent Yield Notes linked to the common stock of GE Vernova Inc. The Notes pay periodic contingent coupons only if the underlying stock closes at or above the coupon barrier on observation dates and may be automatically called quarterly beginning about six months after issuance. If not called, principal is repaid at maturity only if the final level is at or above the downside threshold; otherwise, repayment equals $10 x (1 + underlying return), exposing holders to the full downside of the underlying and potential total loss. Trade date is April 9, 2026, expected settlement April 13, 2026, final valuation April 11, 2028, and maturity April 13, 2028. Payments (coupons or principal) are contingent on UBS creditworthiness. The estimated initial value per Note was $9.80 and the Notes are offered in minimum increments of 100 Notes at $10 per Note.